Smartleaf Asset Management »

Sutro Biopharma shares owned by Smartleaf Asset Management

Quarter-by-quarter ownership of Sutro Biopharma (STRO) shares owned by Smartleaf Asset Management from 13F filings

Historical chart of Smartleaf Asset Management investment in Sutro Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Sutro Biopharma held by Smartleaf Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sutro Biopharma by Smartleaf Asset Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $777 222 3.50

More positions owned by Smartleaf Asset Management

Apple (AAPL)
Microsoft Corporation (MSFT)
Vanguard World Mega Cap Val Etf (MGV)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Meta Platforms Cl A (META)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Wisdomtree Tr Us Quality Grow (QGRW)
Wisdomtree Tr Yield Enhancd Us (AGGY)
Alphabet Cap Stk Cl A (GOOGL)
Wisdomtree Tr Us Qtly Div Grt (DGRW)
Vanguard Intl Equity Index F Tt Wrld St Etf (VT)
Dimensional Etf Trust Us Core Equity 1 (DCOR)
Dimensional Etf Trust Us Core Equity 2 (DFAC)
Ishares Tr Core S&p500 Etf (IVV)

View all positions for Smartleaf Asset Management

Top funds holding Sutro Biopharma

Suvretta Capital Management
BlackRock
BlackRock
Vanguard Group
MPM Oncology Impact Management
Point72 Asset Management
Samsara BioCapital
Citadel Advisors
Kynam Capital Management
Geode Capital Management
Parkman Healthcare Partners
Acadian Asset Management
State Street Corporation
Baillie Gifford & Co
Goldman Sachs Group

View all funds holding Sutro Biopharma